Ozempic is primarily approved for the treatment of type 2 diabetes, with weight loss as a beneficial side effect
Clinical trials and regulatory bodies, including the MHRA (Medicines and Healthcare Products Regulatory Agency) and the EMA (European Medicines Agency), have approved it for managing diabetes and weight loss[1]
Phase 2 trial data showed up to 24 percent weight loss at 48 weeks, suggesting even more potent effects than either semaglutide or tirzepatide alone
Jamie Alan, Ph.D., an associate professor of pharmacology and toxicology at Michigan State University
Use sterile needles for injections
Publisher | Google Scholor Migliorisi G, Gabbiadini R, Dal Buono A, Ferraris M, Privitera G, et al